THE CLINICAL RESEARCH FORUM presented its 2014 Top Ten Clinical Research Achievement Awards during its annual meeting April 10.
The American Society of Clinical Oncology published three clinical practice guidelines for the prevention and management of neuropathy, fatigue, depression, and anxiety.
MICHAEL GORDON was named medical director for the Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute. He will oversee the center's phase I program.
The Securities and Exchange Commission earlier this week said it has settled insider-trading charges against a prominent cancer researcher who was also an executive of a now-defunct company. Loretta Itri was charged with passing information about negative results of a cancer clinical trial to a longtime friend, who then passed the tip on to his... […]
The Case of Kapil MehtaBefore his tenure ran out, Mehta sought to change DePinho's mind. He appealed the decision, and a second independent committee, the Faculty Appeals Panel, supported the PTC recommendation.
The Presidential Veto Within two years, DePinho had vetoed more tenure renewals than the previous president, John Mendelsohn, had in seven. Recent denials of tenure in cases where applicants received unanimous recommendations from the PTC prompted the Executive Committee of the Faculty Senate to investigate the renewal process. “There has been some concern that the... […]
A year before Kapil Mehta's tenure term expired last August, the 11-member Promotions and Tenure Committee at MD Anderson Cancer Center had unanimously recommended renewal.
The Department of Defense announced the availability of several grants through its Ovarian Cancer Research Program and its Lung Cancer Research Program.
The American Cancer Society prefers to avoid public confrontation with corporate donors, even those who make money by selling tobacco products.
When CVS made the decision to forego tobacco sales, the estimated $2 billion in annual revenues it gave up amounts to more than twice the amount of money ACS collects in a year (The Cancer Letter, Feb. 7). However, ACS positions itself as the vanguard of tobacco control, and critics say that close association with a retailer that profits from tobacco undermines the society's own goals and harms its brand.
